Christopher M. Lindblom
Keine laufenden Positionen mehr
Karriereverlauf von Christopher M. Lindblom
Ehemalige bekannte Positionen von Christopher M. Lindblom
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 25.04.2016 | 25.07.2016 |
| Treasurer | 25.07.2016 | 01.10.2016 | |
| DNIB UNWIND INC | Verwaltungsdirektor | 01.03.2014 | 21.03.2016 |
| Finanzdirektor/CFO | 01.03.2014 | 21.03.2016 | |
| Unternehmenssekretär | 01.03.2014 | 21.03.2016 | |
| Treasurer | 01.03.2014 | 21.03.2016 | |
| INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.01.2006 | 12.04.2013 |
| Corporate Officer/Principal | 12.04.2013 | - | |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Finanzdirektor/CFO | 07.06.2013 | 07.06.2013 |
| Corporate Officer/Principal | 07.06.2013 | 19.06.2013 | |
| Treasurer | 19.06.2013 | - |
Ausbildung von Christopher M. Lindblom
| Boston College | Masters Business Admin |
| Syracuse University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Treasurer | 3 |
| Comptroller/Controller/Auditor | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
- Börse
- Insiders
- Christopher M. Lindblom
- Erfahrung